Gastroenteropancreatic neuroendocrine tumor
Clinical trials for Gastroenteropancreatic neuroendocrine tumor explained in plain language.
Never miss a new study
Get alerted when new Gastroenteropancreatic neuroendocrine tumor trials appear
Sign up with your email to follow new studies for Gastroenteropancreatic neuroendocrine tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising cancer drug trial halted after just one patient
Disease control Stopped earlyThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Swiss registry aims to map rare neuroendocrine tumors
Knowledge-focused Stopped earlyNeuroendocrine tumors of the gut and pancreas are rare and not well understood, which makes treatment decisions hard. The SwissNET registry collects health information from patients across Switzerland who have these tumors. Researchers will track tumor types, treatments used, and…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC